Schonfeld Strategic Advisors LLC Mersana Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 2,976,918 shares of MRSN stock, worth $6.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,976,918

Previous 1,008,658 195.14%

Holding current value

$6.1 Million

Previous $4.52 Million 32.43%

% of portfolio

0.04%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.0 - $4.45 $3.94 Million - $8.76 Million	1,968,260 Added 195.14%	2,976,918 $5.98 Million
Q1 2024 May 15, 2024	SELL	$2.16 - $5.94 $282,417 - $776,649	-130,749 Reduced 11.48%	1,008,658 $4.52 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.34 $1.26 Million - $2.67 Million	1,139,407 New	1,139,407 $2.64 Million
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $987,263 - $3.06 Million	320,540 New	320,540 $1.05 Million
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $398,879 - $689,208	86,151 New	86,151 $583,000
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $150,236 - $264,500	-52,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $197,846 - $350,727	52,900 New	52,900 $211,000
Q3 2021 Nov 16, 2021	SELL	$8.56 - $14.47 $192,600 - $325,575	-22,500 Closed	0 $0
Q2 2021 Nov 16, 2021	SELL	$13.28 - $18.07 $203,184 - $276,471	-15,300 Reduced 40.48%	22,500 $306,000
Q2 2021 Aug 16, 2021	SELL	$13.28 - $18.07 $107,594 - $146,403	-8,102 Reduced 17.65%	37,800 $514,000
Q1 2021 May 17, 2021	SELL	$15.31 - $26.52 $1.64 Million - $2.85 Million	-107,435 Reduced 70.06%	45,902 $743,000
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $1.02 Million - $1.67 Million	60,692 Added 65.51%	153,337 $4.08 Million
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $699,969 - $1.11 Million	43,208 Added 87.4%	92,645 $2,000
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $46,793 - $208,962	8,930 Added 22.05%	49,437 $1.16 Million
Q1 2020 May 15, 2020	BUY	$4.41 - $9.28 $132,330 - $278,464	30,007 Added 285.78%	40,507 $236,000
Q4 2019 Feb 14, 2020	BUY	$1.45 - $6.73 $15,225 - $70,665	10,500 New	10,500 $60,000
Q2 2018 Aug 14, 2018	SELL	$14.2 - $22.68 $148,347 - $236,937	-10,447 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.56 - $18.48 $141,661 - $193,060	10,447 New	10,447 $165,000

Others Institutions Holding MRSN

# of Institutions

124

Shares Held

114M

Call Options Held

73.5K

Put Options Held

46.4K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $199M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Mersana Therapeutics, Inc. Transaction History